Subscribe now

Letter: Letter

Published 14 December 2002

From Mike Shaddick

I am long term victim of multiple sclerosis and used to be a biologist. Over the past 30 years I have had intravenous steroids, various interferons, glatiramer acetate and mitoxantone. None of these has made one whit of difference. In your article, Stephen Reingold asserts that the “dozens of publications and regulatory approvals worldwide attest to [the relative benefits of immunoregulatory agents]”.

Where are the MS sufferers who have been cured or, at least, stabilised? Why am I reminded of the way that scientists and manufactures embraced paracetamol (acetaminophen) as the safe alternative to aspirin when I see the various nostrums that are routinely delivered to MS patients?

East Lindfield, NSW, Australia

Issue no. 2373 published 14 December 2002

Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox. We'll also keep you up to date with New Scientist events and special offers.

Sign up
Piano Exit Overlay Banner Mobile Piano Exit Overlay Banner Desktop